Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial

Burn, J, Sheth, H, Elliott, F et al. (20 more authors) (2020) Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial. The Lancet, 395 (10240). pp. 1855-1863. ISSN 0140-6736

Abstract

Metadata

Authors/Creators:
  • Burn, J
  • Sheth, H
  • Elliott, F
  • Reed, L
  • Macrae, F
  • Mecklin, J-P
  • Möslein, G
  • McRonald, FE
  • Bertario, L
  • Evans, DG
  • Gerdes, A-M
  • Ho, JWC
  • Lindblom, A
  • Morrison, PJ
  • Rashbass, J
  • Ramesar, R
  • Seppälä, T
  • Thomas, HJW
  • Pylvänäinen, K
  • Borthwick, GM
  • Mathers, JC
  • Bishop, DT ORCID logo https://orcid.org/0000-0002-8752-8785
  • on behalf of the CAPP2 Investigators
Copyright, Publisher and Additional Information: © 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Dates:
  • Accepted: 7 February 2020
  • Published (online): 11 June 2020
  • Published: 13 June 2020
Institution: The University of Leeds
Funding Information:
FunderGrant number
Cancer Research UKc588/A19167
Depositing User: Symplectic Publications
Date Deposited: 14 Feb 2020 12:34
Last Modified: 14 Oct 2021 21:24
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/S0140-6736(20)30366-4

Share / Export

Statistics